UiPath (NYSE:PATH) Trading Down 3.8% Following Insider Selling

Shares of UiPath, Inc. (NYSE:PATH) were down 3.8% during trading on Wednesday following insider selling activity. The stock traded as low as $15.06 and last traded at $15.3650. Approximately 29,758,370 shares traded hands during mid-day trading, an increase of 6% from the average daily volume of 28,088,309 shares. The stock had previously closed at $15.97.

Specifically, CEO Daniel Dines sold 45,000 shares of the stock in a transaction that occurred on Wednesday, January 14th. The shares were sold at an average price of $15.68, for a total value of $705,600.00. Following the completion of the sale, the chief executive officer directly owned 28,073,585 shares of the company’s stock, valued at approximately $440,193,812.80. This represents a 0.16% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Daniel Dines sold 45,000 shares of UiPath stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $16.61, for a total transaction of $747,450.00. Following the transaction, the chief executive officer directly owned 28,118,585 shares in the company, valued at $467,049,696.85. This represents a 0.16% decrease in their position. The SEC filing for this sale provides additional information. In other UiPath news, CEO Daniel Dines sold 45,000 shares of the company’s stock in a transaction that occurred on Friday, January 9th. The shares were sold at an average price of $17.17, for a total value of $772,650.00. Following the completion of the transaction, the chief executive officer directly owned 28,208,585 shares in the company, valued at $484,341,404.45. This represents a 0.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Analyst Ratings Changes

Several analysts have recently commented on the stock. BMO Capital Markets raised their price objective on shares of UiPath from $13.00 to $17.00 and gave the company a “market perform” rating in a research report on Thursday, December 4th. Morgan Stanley raised their price target on UiPath from $15.00 to $19.00 and gave the company an “equal weight” rating in a report on Tuesday, December 9th. Royal Bank Of Canada dropped their price objective on UiPath from $19.00 to $17.00 and set a “sector perform” rating for the company in a research note on Monday, January 5th. UBS Group reiterated a “neutral” rating on shares of UiPath in a research report on Thursday, December 4th. Finally, Zacks Research raised UiPath from a “hold” rating to a “strong-buy” rating in a report on Tuesday, December 30th. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, fourteen have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, UiPath currently has a consensus rating of “Hold” and an average price target of $16.00.

Key UiPath News

Here are the key news stories impacting UiPath this week:

• Positive Sentiment: UiPath’s Screen Agent (powered by Claude Opus 4.5) ranked No.1 on an OSWorld-verified benchmark for agentic automation — a tangible product validation that supports commercial & technical differentiation. Business Wire: UiPath Screen Agent Ranking
• Positive Sentiment: Unusually heavy call-option activity: investors bought ~134,459 PATH calls (≈54% above normal daily call volume), signaling bullish speculative interest or hedging ahead of catalysts. (trade data)
• Positive Sentiment: Bullish coverage and narratives around AI/automation momentum — e.g., a Seeking Alpha piece argues UiPath is positioned to outperform due to re-accelerating revenue and a path to GAAP profitability, which can attract growth-focused buyers. Seeking Alpha: Why UiPath Is Poised To Outperform
• Neutral Sentiment: Management outreach/visibility: UiPath presented at the Needham Growth Conference (transcript available) — useful for reaffirming guidance and investor Q&A, but not an immediate price driver absent new guidance. Needham Transcript
• Neutral Sentiment: Market positioning and analyst mix remain mixed: institutional inflows and improved momentum metrics are balanced by a MarketBeat consensus “Hold” and a ~$16 price target — implying limited upside from current levels absent stronger guidance or monetization of agentic AI. (market data)
• Negative Sentiment: Insider selling by CEO Daniel Dines: multiple recent blocks of ~45k shares sold across several days (latest filings disclose sales and SEC filing), which can create near-term selling pressure and raise investor concern about timing of sales. SEC filing: Insider Sale
• Negative Sentiment: Headline flow noting shares “sliding today” and elevated volume points to short-term technical/headline-driven selling even as fundamentals show improvement. MSN: Why PATH Shares Are Sliding

UiPath Trading Down 3.8%

The firm has a market cap of $8.22 billion, a P/E ratio of 36.58, a P/E/G ratio of 4.68 and a beta of 1.08. The stock has a 50 day simple moving average of $15.72 and a 200-day simple moving average of $13.89.

UiPath (NYSE:PATH) last posted its earnings results on Wednesday, December 3rd. The company reported $0.16 earnings per share for the quarter, beating analysts’ consensus estimates of $0.14 by $0.02. The firm had revenue of $411.11 million during the quarter, compared to analyst estimates of $392.46 million. UiPath had a net margin of 14.79% and a return on equity of 3.73%. UiPath’s revenue for the quarter was up 15.9% compared to the same quarter last year. During the same period last year, the firm posted $0.11 earnings per share. As a group, equities analysts forecast that UiPath, Inc. will post -0.17 earnings per share for the current fiscal year.

Institutional Trading of UiPath

A number of large investors have recently made changes to their positions in the business. Noble Wealth Management PBC purchased a new position in shares of UiPath in the 4th quarter worth approximately $25,000. Twin Peaks Wealth Advisors LLC bought a new stake in UiPath in the second quarter worth $28,000. AdvisorNet Financial Inc boosted its stake in UiPath by 320.4% during the second quarter. AdvisorNet Financial Inc now owns 2,476 shares of the company’s stock worth $32,000 after buying an additional 1,887 shares during the period. CoreCap Advisors LLC increased its position in UiPath by 92.3% during the fourth quarter. CoreCap Advisors LLC now owns 2,579 shares of the company’s stock valued at $42,000 after acquiring an additional 1,238 shares during the last quarter. Finally, GAMMA Investing LLC increased its position in UiPath by 48.0% during the second quarter. GAMMA Investing LLC now owns 2,989 shares of the company’s stock valued at $38,000 after acquiring an additional 969 shares during the last quarter. 62.50% of the stock is currently owned by institutional investors.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.